Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Anika Therapeutics, Inc.
  6. News
  7. Summary
    ANIK   US0352551081

ANIKA THERAPEUTICS, INC.

(ANIK)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
22.53 USD   -4.13%
06/10ANIKA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
06/10Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
06/10Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ANIKA THERAPEUTICS, INC.
06/10Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
06/10Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
05/20SECTOR UPDATE : Health Care Stocks Gain Premarket Friday
MT
05/20SECTOR UPDATE : Health Care
MT
05/20Anika Therapeutics Says FDA Approves X-Twist System for Soft Tissue Repair
MT
05/20Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Ex..
GL
05/20Anika Receives FDA 510(k) Clearance for the X-Twist Knotless Fixation System, Expanding..
CI
05/20Anika Therapeutics Gets FDA OK for X-Twist Knotless Fixation System
DJ
05/13Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
05/09Anika to Participate in the UBS Global Healthcare Conference 2022
AQ
05/06Tranche Update on Anika Therapeutics, Inc.'s Equity Buyback Plan announced on May 2, 20..
CI
05/05TRANSCRIPT : Anika Therapeutics, Inc., Q1 2022 Earnings Call, May 05, 2022
CI
05/05ANIKA : Q1 Earnings Snapshot
AQ
05/05Earnings Flash (ANIK) ANIKA THERAPEUTICS Posts Q1 Loss $-0.11
MT
05/05Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 Revenue $36.7M, vs. Street Est of $..
MT
More most relevant news
All news about ANIKA THERAPEUTICS, INC.
06/10ANIKA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Submission of Matter..
AQ
06/10Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
06/10Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
05/20SECTOR UPDATE : Health Care Stocks Gain Premarket Friday
MT
05/20SECTOR UPDATE : Health Care
MT
05/20Anika Therapeutics Says FDA Approves X-Twist System for Soft Tissue Repair
MT
05/20Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Ex..
GL
05/20Anika Receives FDA 510(k) Clearance for the X-Twist Knotless Fixation System, Expanding..
CI
05/20Anika Therapeutics Gets FDA OK for X-Twist Knotless Fixation System
DJ
05/13Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
More news
News in other languages on ANIKA THERAPEUTICS, INC.
05/20MISE À JOUR SECTORIELLE : Les actions du secteur de la santé progressent vendredi avant le..
05/20MISE À JOUR SECTORIELLE : Soins de santé
05/20Anika Therapeutics déclare que la FDA approuve le système X-Twist pour la réparation de..
05/20Anika reçoit l'autorisation 510(k) de la FDA pour le système de fixation sans nœud X-Tw..
05/05Earnings Flash (ANIK) ANIKA THERAPEUTICS annonce un chiffre d'affaires de 36,7 millions..
05/05Anika Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mar..
05/05Anika Therapeutics, Inc. fournit des prévisions de revenus pour l'année 2022
03/14ACHAT D'INITIÉS : Anika Therapeutics
03/09L'action d'Anika Therapeutics plonge mercredi après la rétrogradation de Stephens
03/08Anika Therapeutics enregistre une perte au quatrième trimestre, mais son chiffre d'affa..
More news
Analyst Recommendations on ANIKA THERAPEUTICS, INC.
03/09Stephens Downgrades Anika Therapeutics to Equalweight from Overweight, Adjusts Price Ta..
MT
2021Stephens Starts Anika Therapeutics at Overweight With $55 Price Target
MT
2021Barrington Adjusts Price Target on Anika Therapeutics to $48 From $44, Keeps Outperform..
MT
2021ANIKA THERAPEUTICS : UBS Starts Anika Therapeutics at Neutral With $46 Price Target
MT
2020ANIKA THERAPEUTICS : Barrington Research Upgrades Anika Therapeutics to Outperform From Ma..
MT
More recommendations
Press releases
06/10ANIKA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Submission of Matter..
AQ
06/10Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
06/10Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
05/20Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Ex..
GL
05/13Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
More press releases
Upcoming event on ANIKA THERAPEUTICS, INC.
07/27/22Interim 2022 Earnings Release (Projected)
Upcoming sector events
07/26/22BIOGEN INC. : Interim 2022 Earnings Release (Projected)
08/16/22SAMSUNG BIOLOGICS CO.,LTD. : Interim 2022 Earnings Release (Projected)
08/17/22CSL LIMITED : FY 2022 Earnings Release
08/22/22WUXI BIOLOGICS (CAYMAN) INC. : Interim 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals